Cover Image

2023 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy- and chemoradiotherapy-induced nausea and vomiting

Radiotherapy and chemoradiotherapy-induced nausea and vomiting (RINV and C-RINV) are common and distressing, and there is a need for guidance for clinicians to provide up to date optimal antiemetic prophylaxis and treatment. Through a comprehensive review of the literature concerning RINV and C-RINV...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruhlmann, Christina H. (Author) , Jordan, Karin (Author) , Jahn, Franziska (Author) , Maranzano, Ernesto (Author) , Molassiotis, Alex (Author) , Dennis, Kristopher (Author)
Format: Article (Journal)
Language:English
Published: 15 December 2023
In: Supportive care in cancer
Year: 2023, Volume: 32, Issue: 1, Pages: 1-9
ISSN:1433-7339
DOI:10.1007/s00520-023-08226-z
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00520-023-08226-z
Get full text
Author Notes:Christina H. Ruhlmann, Karin Jordan, Franziska Jahn, Ernesto Maranzano, Alex Molassiotis, Kristopher Dennis
Description
Summary:Radiotherapy and chemoradiotherapy-induced nausea and vomiting (RINV and C-RINV) are common and distressing, and there is a need for guidance for clinicians to provide up to date optimal antiemetic prophylaxis and treatment. Through a comprehensive review of the literature concerning RINV and C-RINV, this manuscript aims to update the evidence for antiemetic prophylaxis and rescue therapy and provide a new edition of recommendations for the MASCC/ESMO antiemetic guidelines for RINV and C-RINV.
Item Description:Gesehen am 08.04.2024
Physical Description:Online Resource
ISSN:1433-7339
DOI:10.1007/s00520-023-08226-z

Similar Items